Kathrin Maedler

Director; Islet Biology Laboratory

University of Bremen
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2026

Year:

2026

Aims/hypothesis Previous pathology studies have associated enterovirus infections with type 1 diabetes by examining the enterovirus capsid protein 1 (VP1) in autopsy pancreases obtained near diabetes diagnosis. The Network for Pancreatic Organ Donors with Diabetes (nPOD) has since obtained pancreases from organ donors with type 1 diabetes (with broad age and disease duration) and donors with disease-associated autoantibodies (AAbs), the latter representing preclinical disease. Two accompanying manuscripts from the nPOD-Virus Group report primary data from a coordinated analysis of multiple enterovirus indices. We aimed to comprehensively assess the association of multiple enterovirus markers with type 1 diabetes. Methods The nPOD-Virus Group examined pancreases from 197 donors, recovered between 2007 and 2019, classified into five groups: donors with type 1 diabetes, with residual insulin-containing islets (T1D-ICI group, n =41) or with only insulin-deficient islets (T1D-IDI, n =42); donors without diabetes who are AAb-negative (ND, n =83); and rare donors without diabetes expressing a single AAb (AAb + , n =22) or multiple AAbs (AAb ++ , n =9). We assessed the overall association of multiple indicators of enterovirus infection, case-by-case and between donor groups, as well as assay agreement and reproducibility, using various statistical methods. We examined data from 645 assays performed across 197 nPOD donors. Results Detection of enterovirus indices by independent laboratories had high reproducibility, using both enterovirus-targeted and unbiased methods. T1D-ICI donors had significantly higher ( p <0.001) proportions of positive assay outcomes (58.4%) vs T1D-IDI (10.3%), ND (17.8%) and AAb-positive donors (AAb + 24.6%; AAb ++ 35.0%). Head-to-head comparisons revealed increased proportions of donors positive in two independent assays among T1D-ICI vs ND donors (VP1/HLA class I [HLA-I], p <0.0001; VP1/enterovirus-specific RT-PCR (EV-PCR), p =0.076; EV-PCR/HLA-I, p =0.016; proteomics/HLA-I, p <0.0001; VP1/proteomics, p =0.06). Among 110 donors examined for three markers (VP1, EV-PCR and HLA-I), 83.3% of T1D-ICI donors were positive in two or more assays vs 0% of ND ( p <0.001), 26.7% of AAb + ( p =0.006), 28.6% of AAb ++ ( p =0.023) and 0% of T1D-IDI ( p <0.001) donors. Conclusions/interpretation The nPOD-Virus Group conducted, to date, the largest and most comprehensive analysis of multiple indices of pancreatic enterovirus infections in type 1 diabetes; these were more prevalent in T1D-ICI and AAb ++ donors than in other groups. Their preferential detection of these indices in donors with residual beta cells and autoimmunity implicates enterovirus infections across disease progression stages and supports a contribution to beta cell loss, directly or indirectly, even after diagnosis. The relatively small number of infected cells and the low amount of viral RNA support the existence of non-acute, low level, possibly persistent enterovirus infections in the pancreas. Graphical Abstract

Year:

2025

While pancreatic beta-cell proliferation has been extensively studied, the role of cell death during islet development remains incompletely understood. Using a genetic model of caspase inhibition in beta cells coupled with mathematical modeling, we here discover an onset of beta-cell death in juvenile zebrafish, which regulates beta-cell mass. Histologically, this beta-cell death is underestimated due to phagocytosis by resident macrophages. To investigate beta-cell apoptosis at the molecular level, we implement a conditional model of beta-cell death linked to Ca 2+ overload. Transcriptomic analysis reveals that metabolically-stressed beta cells follow paths to either de-differentiation or apoptosis. Beta cells destined to die activate inflammatory and immuno-regulatory pathways, suggesting that cell death regulates the crosstalk with immune cells. Consistently, inhibiting beta-cell death during development reduces pro-inflammatory resident macrophages and expands T-regulatory cells, the deficiency of which causes premature activation of NF-kB signaling in beta cells. Thus, developmental cell death not only shapes beta-cell mass but it also influences the islet’s inflammatory milieu by shifting the immune-cell population towards pro-inflammatory.

Year:

2025

Year:

2025

Plants have evolved sophisticated mechanisms to perceive and interpret daytime in order to flower at an optimal time point. Here we show that the spliceosomal component GAMETOPHYTIC FACTOR 1 ( GFA1 ) constitutes a previously unrecognized key photoperiodic switch, that is essential for flowering in long days. We show that gfa1 hypomorphic ( gfa1 hyp ) plants fail to initiate flowering in long-days (LD), which correlates with ectopic activation of the short-day (SD) flowering repressor ARABIDOPSIS THALIANA CENTRORADIALIS (ATC) . Accordingly, flowering is restored upon inactivation of ATC in gfa1 hyp mutants. A novel tissue-specific in-planta splice assay and comprehensive RNAseq profiling of gfa1 hyp mutants indicate that GFA1 mediated pre-mRNA splicing is substrate specific, as previously suggested for GFA1 orthologs. Furthermore, we show that gfa1 hyp mutants accumulate nonsense transcripts of the photoreceptor components PHYB and RRC1 , suggesting inappropriate photoreceptor signaling as a potential cause for the ectopic activation of the SD characteristic profile in gfa1 hyp . In fact, known downstream targets of the phytochrome system such as RS31, SR34a, SRp30 accumulate reduced amounts of light-dependent splice isoforms. Together, our data reveal a link between spliceosome composition and long-day flowering, based on complex transcriptional readouts in response to day length.

Year:

2024

Collaborators (9)

John Kaddis

Beckman Research Institute

UNITED STATES
View details

Sarah Richardson

Professor of Cellular Biomedicine

University of Exeter

UNITED KINGDOM
View details

Julius O Nyalwidhe

Professor and Director, Center for Biomedical Proteomics

Eastern Virginia Medical School

UNITED STATES
View details

Lieven Sterck

Universiteit Gent

BELGIUM
View details

Sumeet Pal Singh

Associate Professor

Université libre de Bruxelles (ULB)

BELGIUM
View details

Nikolay Ninov

Professor "Cell Biology and Regeneration of Beta-cells"

Technische Universität Dresden

GERMANY
View details

Rita Groß-Hardt

Prof.Dr

University of Bremen

GERMANY
View details

Yves Van de Peer

VIB-UGent Center for Plant Systems Biology

BELGIUM
View details

Joseph Petrosino

Department Chair

Baylor College of Medicine

UNITED STATES
View details